Regeneron Pharmaceuticals Incorporated

California

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Cases6
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
Biotech
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
11/15/24
ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. [394] , [395] ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024)
06/17/24
SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024)
08/03/21
REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # [1] Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021)
08/03/21
REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # 1 Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021)
08/03/21
ORDER GRANTING JOINT MOTION TO DISMISS by Judge Andre Birotte Jr.: The parties joint motion to dismiss pursuant to Federal Rule of Civil Procedure 4l(a)(2) and (c) 402 is GRANTED. All of Immunexs claims as to Defendants in the action are hereby DISMISSED WITH PREJUDICE. All of Defendants counterclaims in the action are hereby DISMISSED WITHOUT PREJUDICE. As the prevailing party, Defendants shall be entitled to their costs amounting to $39,811.80 to be paid to Defendants within 30 days of the Courts order of dismissal. Each party shall bear its own attorneys fees. ( MD JS-6. Case Terminated ) (gk) (Entered: 08/03/2021)